Regular prophylactic treatment with FVIII concentrate, including extended half-life FVIII concentrate (EHL-FVIII), helps to prevent joint bleeding and damage in severe cases of hemophilia [1,2,3,4]. The gene discussed is F8; the disease is hemophilia.